Accelerate Cambridge Ventures Hall of Fame

Since 2013, we have helped hundreds of entrepreneurs turn an idea into a business, and we are very proud of their many achievements. Here are some of our Accelerate Cambridge ventures that have been most successful in securing funds from investors.

Venture	Founded in	Funds raised	Employees	Industry
bit.bio bit.bio is a synthetic biology company providing human cells for research, drug discovery and cell therapy. View venture	2016	£124m	101-250	Healthcare, pharma, biotech
Healx Healx is a social enterprise passionate about finding new therapeutic solutions to cure patients with rare diseases. View venture	2014	£66.4m	51-100	Healthcare, pharma, biotech
Speechmatics Speechmatics provides cloud-based speech recognition services that convert speech-to-text. View venture	2006	£60.1m	101-250	Technology
Nuclera Nuclera is a US and UK-based biotechnology company driven by the mission to better human health by making proteins accessible. View venture	2013	£52.3m	101-250	Healthcare, pharma, biotech
VocalIQ VocalIQ was formed in March 2011 to exploit technology developed by the Spoken Dialogue Systems Group at University of Cambridge, UK. View venture	2011	£49.5m	1-10	Computing, data, software
Cytora Cytora is the configurable platform that enables commercial insurers to create digital workflows by digitising, evaluating and routing risks. View venture	2014	£31.6m	11-50	Risk management
PostEra PostEra is the first company to algorithmically complete the ‘design-make-test’ cycle of drug discovery. View venture	2019	£20.8m	11-50	Healthcare, pharma, biotech
Better Origin Better Origin sets out to transform food waste into sustainable products with the help of insects. View venture	2015	£19.2m	11-50	ESG, climate action
Hummingbird Technologies Hummingbird Technologies is an artificial intelligence SaaS platform that provides actionable intelligence to farmers and agri-businesses at key decision-making times in the growing season. View venture	2015	£16.5m	11-50	Engineering
PharmEnable PharmEnable explores new areas of chemical space that no one else is currently searching to enable the development of vital new medicines. View venture	2016	£12.2m	1-10	Healthcare, pharma, biotech
Dogtooth Technologies Dogtooth Technologies is a Cambridge-based technology start-up that sells smart robots for harvesting soft fruits such as strawberries and raspberries. View venture	2014	£11.8m	11-50	Agritech
Sano Genetics Sano’s patient finding and engagement services enable researchers to deliver precision medicine clinical trials at increased speed and lower cost. View venture	2017	£11.8m	60	Healthcare, pharma, biotech
FA-Bio FA-Bio provides game-changing bio-products for agriculture that can replace chemical inputs. View venture	2015	£9.5m	1-10	Agriculture
Charco Neurotech Charco Neurotech developed CUE1, a focused vibrotactile stimulation device for people with Parkinson’s. View venture	2019	£8.7m	11-50	Healthcare, pharma, biotech
KisanHub-Arjun Technology Ventures KisanHub Agri-Food Supply Chain software helps producer groups to transform their supply chain and improve margins with greater visibility and data driven insights. View venture	2014	£7.3m	11-50	Agriculture
Cambridge Cancer Genomics Cambridge Cancer Genomics developed precision oncology solutions to transform the way cancer patients are treated. View venture	2016	£7.2m	11-50	Healthcare, pharma, biotech
MediaGamma/Nozzle ai MediaGamma is transforming the way digital media is valued, traded, and measured. View venture	2014	£5.8m	11-50	Arts, entertainment, media
Antiverse Antiverse is developing a revolutionary technology to predict antibody drug hits in a single day rather than in months through the traditional methods. View venture	2017	£5.3m	11-50	Pharmaceutical
Spotta Spotta intends to be the world leader in smart pest detection. View venture	2008	£5.1m	1-10	Agriculture
Prosoma Prosoma is developing a comprehensive digital therapeutics programme, designed exclusively for cancer patients, including CBT, RBT, mindfulness, relaxation and breathing therapies. View venture	2017	£4.7m	11-150	Healthcare, pharma, biotech
Polysolar Polysolar produces window glass that generates electricity. View venture	2007	£4.6m	1-10	Construction, engineering
Edozo Edozo is an online community for commercial property professionals who wish to share high quality comparable evidence. View venture	2016	£4.6m	11-50	Real estate
52North 52 North was launched to develop a transformative new medical device, NeutroCheck, presenting tangible efficiencies in patient care and healthcare resource, both financial and human. View venture	2018	£4.3m	1-10	Healthcare, pharma, biotech
Satavia Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market. View venture	2013	£4.06m	11-50	Automotive, aerospace
Animal Alternative Technologies Satavia is an analytics and visualisation company that develops bespoke environmental awareness solutions for all segments of the aviation market. View venture	2020	£3.9m	1-10	Manufacturing
Spirea Spirea is developing the next generation of antibody drug conjugate cancer therapeutics. View venture	2017	£2.9m	1-10	Healthcare, pharma, biotech
Syrona Health Syrona Health, a non-invasive, rapid diagnostic tool helps women better manage their own reproductive health. View venture	2019	£2.6m	11-50	Healthcare, pharma, biotech
Kalium Health Kalium Health is developing the world’s first blood potassium test suitable for home use. View venture	2018	£2.5m	11-50	Healthcare, pharma, biotech
Qureight Qureight combines technology and life sciences to generate new knowledge and transform the way we use clinical data. View venture	2018	£2.5m	1-10	Healthcare, pharma, biotech
Upfront diagnostics LTD Upfront Diagnostics has discovered and validated novel blood biomarkers for the detection of stroke patients suffering from a large vessel occlusion. View venture	2017	£2.5m	1-10	Healthcare, pharma, biotech